Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO Trial

Clinical trial NCT06995508 · RECRUITING

Trial details

NCT number: NCT06995508
Sponsor: Roswell Park Cancer Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cancer-Associated Anorexia Head and Neck Squamous Cell Carcinoma Neck Squamous Cell Carcinoma of Unknown Primary

Start date: 2025-12-24
Primary completion: 2030-11-15
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.